Promega ApoLive-Glo™ Multiplex Assay

Description

Includes

GF-AFC Substrate, Assay Buffer, Caspase-Glo 3/7 Buffer, Caspase-Glo 3/7 Substrate

The ApoLive-Glo™ Multiplex Assay measures both the number of viable cells as a marker of cytotoxicity and caspase activation as a marker of apoptosis within a single assay well to determine the mechanism of cell death.

• Measure Viability and Apoptosis in the Same Sample Well
• Accurately determine mechanism of cell death in less time, with less sample
• Easy to implement using a simple sequential 'add-mix-measure' protocol
• Adaptable to meet various throughput needs

Specifications

• Quantity: 10 mL
• Detection Method: Fluorescence, Luminescence
• For Use With (Application): Profile Compounds for Cytotoxic Risk
• Kit Contents: 1 x 10 μL GF-AFC substrate, 1 x 10 mL Assay Buffer, 1 x 10 mL Caspase-Glo 3/7 Buffer, 1 x 1 bottle Caspase-Glo 3/7 substrate
• Format: Bottle
• Content And Storage: -30°C to -10°C

• U.S. Patents 7,416,854; 7,553,632 and other patents pending.
• U.S. Patents 6,602,677 and 7,241,584, Australian Patents 754312 and 785294 and other patents and patents pending.
• U.S. Patents 7,148,030 and 7,384,758, Australian Patent 2003216139 and other patents pending.
• The method of recombinant expression of Coleoptera luciferase is covered by U.S. Patents 5,583,024, 5,674,713 and 5,700,673.